Literature DB >> 18810375

[Pathophysiology of bone metabolism].

F Jakob1, L Seefried, R Ebert.   

Abstract

Osteoporosis is a multifactorial disease entailing a high risk to sustain fragility fractures. Its susceptibility is determined by genetic and environmental factors and underlying diseases. Bone is rebuilt and regenerated by osteoclasts, osteoblasts and osteocytes. Local and systemic growth and differentiation factors such as Insulin-like growth factors, bone morphogenetic proteins and wnt-proteins confer anabolic signals, while the RANK/RANK-Ligand and Osteoprotegerin (OPG) system regulates bone resorption. The ratio of osteoclast stimulating RANKL and its soluble decoy receptor OPG is modulated by sex hormones, vitamin D, parathyroid hormone, local growth factors and mechanical loading. Osteocytes regulate bone mass via the bone formation inhibitor sclerostin. Bone is tightly interconnected with and regulated by the calcium/phosphate/vitamin D system via the parathyroid gland, the gut, liver and kidneys. Sex hormones are important for bone formation during adolescence and their loss in menopause/andropause exaggerates bone resorption. Basically over-activity of osteoclasts and/or functional deficits of osteoblasts can cause negative bone balance and favor osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18810375     DOI: 10.1007/s00108-008-2113-0

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  32 in total

Review 1.  Incidence and prevalence of medication-induced osteoporosis: evidence-based review.

Authors:  Juliette Allport
Journal:  Curr Opin Rheumatol       Date:  2008-07       Impact factor: 5.006

2.  A prospective study of dietary calcium, dairy products and prostate cancer risk (Finland).

Authors:  Panagiota N Mitrou; Demetrius Albanes; Stephanie J Weinstein; Pirjo Pietinen; Philip R Taylor; Jarmo Virtamo; Michael F Leitzmann
Journal:  Int J Cancer       Date:  2007-06-01       Impact factor: 7.396

Review 3.  Drug-induced osteoporosis: beyond glucocorticoids.

Authors:  Karine Briot; Christian Roux
Journal:  Curr Rheumatol Rep       Date:  2008-04       Impact factor: 4.592

Review 4.  The osteocyte lineage.

Authors:  Brendon S Noble
Journal:  Arch Biochem Biophys       Date:  2008-04-18       Impact factor: 4.013

Review 5.  Vitamin D signaling is modulated on multiple levels in health and disease.

Authors:  Regina Ebert; Norbert Schütze; Jerzy Adamski; Franz Jakob
Journal:  Mol Cell Endocrinol       Date:  2006-01-09       Impact factor: 4.102

Review 6.  Anabolic agents and the bone morphogenetic protein pathway.

Authors:  I R Garrett
Journal:  Curr Top Dev Biol       Date:  2007       Impact factor: 4.897

Review 7.  Understanding the mechanisms of senile osteoporosis: new facts for a major geriatric syndrome.

Authors:  Gustavo Duque; Bruce R Troen
Journal:  J Am Geriatr Soc       Date:  2008-05       Impact factor: 5.562

Review 8.  Bone and fat connection in aging bone.

Authors:  Gustavo Duque
Journal:  Curr Opin Rheumatol       Date:  2008-07       Impact factor: 5.006

Review 9.  Building bone to reverse osteoporosis and repair fractures.

Authors:  Sundeep Khosla; Jennifer J Westendorf; Merry Jo Oursler
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

Review 10.  Rebalancing bone turnover in favour of formation with strontium ranelate: implications for bone strength.

Authors:  J E Fonseca
Journal:  Rheumatology (Oxford)       Date:  2008-07       Impact factor: 7.580

View more
  2 in total

Review 1.  [Age and osteoporosis. Effects of aging on osteoporosis, the diagnostics and therapy].

Authors:  F Jakob; L Seefried; M Schwab
Journal:  Internist (Berl)       Date:  2014-07       Impact factor: 0.743

2.  [Bone metastasis in prostate cancer].

Authors:  F Moltzahn; G N Thalmann
Journal:  Urologe A       Date:  2012-01       Impact factor: 0.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.